FIELD: medicine, oncology. SUBSTANCE: it is suggested to inject preparation into portal vein of hepatic lobe-target (lobe-tumor-carrier) at occlusion of both afferent and efferent lobar vessels for 5-15 min. Teraphthal is used as such a preparation and after occlusion is over one should additionally inject ascorbic acid into the branch of portal vein. Or photosens is used as such a preparation and 10-35 min after occlusion is over one should carry out laser irradiation of tumor. The method provides predominant accumulation of preparations in hepatic lobe-target, their poor penetration into systemic blood flow that enables to decrease the dosage of preparation and its total toxicity. EFFECT: higher efficiency. 2 cl, 1 dwg, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF LIVER METASTASES | 2011 |
|
RU2474423C1 |
METHOD FOR MODIFYING PHOTODYNAMIC THERAPY | 2010 |
|
RU2449821C1 |
SULFOSUBSTITUTED PHTHALOCYANINES AS PHOTOSENSITIZING AGENTS FOR PHOTODYNAMIC THERAPY | 1999 |
|
RU2183635C2 |
METHOD FOR TUMOUR GROWTH INHIBITION | 2012 |
|
RU2491930C1 |
METHOD FOR PHOTODYNAMIC THERAPY OF PATIENTS WITH METASTATIC TUMOURAL PLEURITIS | 2013 |
|
RU2514107C1 |
MEANS AND METHOD FOR APPLYING PHOTODYNAMIC THERAPY | 2004 |
|
RU2271801C2 |
PHOTOSENSITIZING AGENTS FOR PHOTODYNAMIC THERAPY | 2005 |
|
RU2282646C1 |
BIOTISSUE PHANTOM AND INDICATOR FOR PHOTOSENSITIZER'S CONTENT | 2001 |
|
RU2210315C2 |
WATER-SOLUBLE DOSAGE FORM OF MESO-TETRA(3-PYRIDYLE)BACTERIOCHLORIN FOR PHOTODYNAMIC THERAPY | 2017 |
|
RU2663900C1 |
METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE IN AN EXPERIMENT | 2003 |
|
RU2255699C2 |
Authors
Dates
2003-03-20—Published
2000-12-07—Filed